Advertisement

Molecular Alterations in Dysplasia and Superficial Cancer of the Esophagus

  • Soji Ozawa
  • Yoshifumi Ikeda
  • Kazuo Koyanagi
  • Nobutoshi Ando
  • Yuko Kitagawa
  • Masakazu Ueda
  • Masaki Kitajima
Conference paper

Abstract

Many molecular alterations may contribute to the pathogenesis of esophageal cancer. We reviewed the results of our molecular studies on dysplasia and cancer of the esophagus. In this paper we focus on expression of the oncogenes c-erb-B and int-2/cyclin Dl, and teIomerase activity in superficial esophageal cancer.

Keywords

Esophageal Cancer Esophageal Squamous Cell Carcinoma Telomeric Repeat Amplification Protocol Dysplastic Lesion Telomeric Repeat Amplification Protocol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kitagawa Y, Ueda M, Ando N, et al (1996) Further evidence for prognostic significance of epidermal growth factor receptor gene amplification in patients with esophageal squamous cell carcinoma. Clin Cancer Res 2:909–914PubMedGoogle Scholar
  2. 2.
    Kitagawa Y, Ueda M, Ando N, et al (1991) Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51:1504–1508PubMedGoogle Scholar
  3. 3.
    Shinozaki H, Ozawa S, Ando N, et al (1996) Cyclin Dl amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information. Clin Cancer Res 2:1155–1161PubMedGoogle Scholar
  4. 4.
    Ikeda Y, Ozawa S, Ando N, et al (1996) Meanings of c-erbB and int-2 amplification in superficial esophageal squamous cell carcinomas. Ann Thorac Surg 62:835–838PubMedCrossRefGoogle Scholar
  5. 5.
    Dubeau L, Chandler LA, Gralow JR, et al (1986) Southern blot analysis of DNA extracted from formalin-fixed pathology specimens. Cancer Res 46:2964–2969PubMedGoogle Scholar
  6. 6.
    Endo M, Takeshita K, Yoshida M (1986) How can we diagnose the early stage of esophageal cancer? Endoscopy 18(suppl 3):11–18PubMedCrossRefGoogle Scholar
  7. 7.
    Koyanagi K, Ozawa S, Ando N, et al (2000) Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus. Cancer 88:1524–1529PubMedCrossRefGoogle Scholar
  8. 8.
    Kim NW, Piatyszek MA, Prowse KR, et al (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011–2015PubMedCrossRefGoogle Scholar
  9. 9.
    Koyanagi K, Ozawa S, Ando N, et al (1999) Clinical significance of telomerase activity in the non-cancerous epithelial region of oesophageal squamous cell carcinoma. Br J Surg 86:674–679PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2002

Authors and Affiliations

  • Soji Ozawa
    • 1
  • Yoshifumi Ikeda
    • 1
  • Kazuo Koyanagi
    • 1
  • Nobutoshi Ando
    • 1
  • Yuko Kitagawa
    • 1
  • Masakazu Ueda
    • 1
  • Masaki Kitajima
    • 1
  1. 1.Department of Surgery, School of MedicineKeio UniversityTokyoJapan

Personalised recommendations